1 Laboratory of Endocrine Physiology, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil .
2 Laboratory of Molecular Radiobiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro , Rio de Janeiro, Brazil .
Thyroid. 2018 Feb;28(2):265-275. doi: 10.1089/thy.2016.0585. Epub 2017 Dec 21.
Thyroid iodide uptake, mediated by the sodium-iodide symporter (NIS), is essential for thyroid hormone synthesis and also for treatment of thyroid diseases, such as thyroid cancer, through radioiodine therapy. Therefore, compounds able to increase thyroid iodide uptake could be clinically useful, and it is of great importance to unravel the mechanisms underlying such an effect. It has been shown previously that the flavonoid rutin increases thyroid radioiodide uptake in vivo in rats. This study aimed to investigate the mechanisms involved in the stimulatory effect of rutin on iodide uptake.
This study evaluated iodide uptake, NIS expression and its subcellular distribution, iodide efflux, reactive oxygen species levels, and the intracellular pathways involved in NIS regulation in a rat thyroid PCCL3 cell line treated with rutin.
Similar to previous results found in vivo, rutin increased radioiodide uptake in PCCL3 cells, which was accompanied by increased NIS expression (at both the mRNA and protein levels) and a reduction of radioiodide efflux. Moreover, the results suggest that rutin could regulate NIS subcellular distribution, leading to higher levels of NIS at the cell membrane. In addition, rutin decreased the levels of intracellular reactive oxygen species and phospho-5'-adenosine monophosphate-activated protein kinase.
The flavonoid rutin seems to be an important stimulator of radioiodide uptake, acting at multiple levels, an effect that can be due to decreased oxidative stress, reduced 5'-adenosine monophosphate-activated protein kinase activation, or both. Since thyroid iodide uptake is crucial for effective radioiodine therapy, the results suggest that rutin could be useful as an adjuvant in radioiodine therapy.
甲状腺碘摄取是由钠-碘同向转运体(NIS)介导的,对于甲状腺激素的合成以及通过放射性碘治疗治疗甲状腺疾病(如甲状腺癌)都是至关重要的。因此,能够增加甲状腺碘摄取的化合物在临床上可能是有用的,并且阐明这种作用的机制具有重要意义。先前已经表明,类黄酮芦丁可在体内增加大鼠的甲状腺放射性碘摄取。本研究旨在研究芦丁对碘摄取的刺激作用所涉及的机制。
本研究评估了芦丁对碘摄取、NIS 表达及其亚细胞分布、碘流出、活性氧水平以及参与 NIS 调节的细胞内途径的影响,在使用芦丁处理的大鼠甲状腺 PCCL3 细胞系中进行了评估。
与体内先前的结果相似,芦丁增加了 PCCL3 细胞中的放射性碘摄取,这伴随着 NIS 表达的增加(在 mRNA 和蛋白质水平上)和放射性碘流出的减少。此外,结果表明芦丁可以调节 NIS 的亚细胞分布,导致细胞膜上 NIS 水平更高。此外,芦丁降低了细胞内活性氧和磷酸-5'-腺嘌呤单磷酸激活蛋白激酶的水平。
类黄酮芦丁似乎是放射性碘摄取的重要刺激剂,作用于多个水平,这种作用可能是由于氧化应激减少、5'-腺嘌呤单磷酸激活蛋白激酶激活减少或两者兼而有之。由于甲状腺碘摄取对于有效的放射性碘治疗至关重要,因此结果表明芦丁可作为放射性碘治疗的辅助剂。